Twenty-six entrepreneurs from the Highlands and Islands have embarked on the final edition of the Pathfinder Accelerator, a four-month programme led by Highlands and Islands Enterprise (HIE), aimed at expediting their journey to business success.
Cancer Research UK has announced that it will award up to £123 million over a seven-year funding commitment to Glasgow’s Beatson Institute for Cancer Research.
Scotland-based rocket firm, Orbex, has announced it will feature at the UK Space Agency’s ‘Space for Everyone’ event in Glasgow’s George Square on the 21 to 22 September.
Scottish health tech firm Emblation has officially commenced its move into a new £4 million headquarters in Stirling, ushering in the start of a new era.
Research into the relationship between financial vulnerability and mental health, and the development of a portable system for monitoring hormonal fluctuations, are among the latest projects to have been backed by a national inward investment fund.
Scottish scaleup Krucial, which utilises space technology to provide digital solutions, has secured further funding of more than $3.7mn as it continues to expand into international markets.
Glasgow-based medical start-up Microplate Dx has successfully closed a £2.5 million seed funding round to accelerate the development of its point-of-care diagnostic platform.
Livingston-based prosthetic technology specialist, Össur, has secured a £400,000 research and development grant from Scottish Enterprise, as part of a £2 million project aimed at advancing upper limb prosthetic technologies.
A Scottish Government-backed delegation is travelling to Norway this week to showcase the strength of the country’s aquaculture supply chain and boost international trade opportunities for SMEs.
Glasgow-based integrated drug formulation and clinical trials specialist BDD has secured a fresh £2 million investment to fuel its expansion, responding to a surge in demand for its proprietary drug delivery technology and its niche clinical trial services.
Edinburgh-based life science firm, Cytomos, has successfully raised £4 million in a recent investment round for the development and market-testing of its Cytomos Dielectric Spectroscopy (CDS) technology.
Scottish health tech firm Emblation has unveiled its new £4 million state-of-the-art headquarters located in Stirling, marking a significant milestone in the firm’s global expansion journey.
Emblation, the Alloa-based health-tech innovator is undertaking a rigorous clinical trial which could transform the fortunes of its microwave treatments in the US.